JP2023513655A5 - - Google Patents

Info

Publication number
JP2023513655A5
JP2023513655A5 JP2022525958A JP2022525958A JP2023513655A5 JP 2023513655 A5 JP2023513655 A5 JP 2023513655A5 JP 2022525958 A JP2022525958 A JP 2022525958A JP 2022525958 A JP2022525958 A JP 2022525958A JP 2023513655 A5 JP2023513655 A5 JP 2023513655A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
independently
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022525958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513655A (ja
JP7659553B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059552 external-priority patent/WO2021092500A1/en
Publication of JP2023513655A publication Critical patent/JP2023513655A/ja
Publication of JP2023513655A5 publication Critical patent/JP2023513655A5/ja
Priority to JP2025054317A priority Critical patent/JP2025118594A/ja
Application granted granted Critical
Publication of JP7659553B2 publication Critical patent/JP7659553B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022525958A 2019-11-08 2020-11-06 アポトーシス阻害（ｉａｐ）タンパク質アンタゴニスト Active JP7659553B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025054317A JP2025118594A (ja) 2019-11-08 2025-03-27 アポトーシス阻害（ｉａｐ）タンパク質アンタゴニスト

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962933190P 2019-11-08 2019-11-08
US62/933,190 2019-11-08
PCT/US2020/059552 WO2021092500A1 (en) 2019-11-08 2020-11-06 Inhibitor of apoptosis (iap) protein antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025054317A Division JP2025118594A (ja) 2019-11-08 2025-03-27 アポトーシス阻害（ｉａｐ）タンパク質アンタゴニスト

Publications (3)

Publication Number Publication Date
JP2023513655A JP2023513655A (ja) 2023-04-03
JP2023513655A5 true JP2023513655A5 (enExample) 2023-10-18
JP7659553B2 JP7659553B2 (ja) 2025-04-09

Family

ID=75849612

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022525958A Active JP7659553B2 (ja) 2019-11-08 2020-11-06 アポトーシス阻害（ｉａｐ）タンパク質アンタゴニスト
JP2025054317A Pending JP2025118594A (ja) 2019-11-08 2025-03-27 アポトーシス阻害（ｉａｐ）タンパク質アンタゴニスト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025054317A Pending JP2025118594A (ja) 2019-11-08 2025-03-27 アポトーシス阻害（ｉａｐ）タンパク質アンタゴニスト

Country Status (5)

Country Link
US (1) US20230115837A1 (enExample)
EP (1) EP4058454A4 (enExample)
JP (2) JP7659553B2 (enExample)
CA (1) CA3160666A1 (enExample)
WO (1) WO2021092500A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR117206A1 (es) * 2018-11-30 2021-07-21 Glaxosmithkline Ip Dev Ltd Derivados de octahidropirrolo[2,1-b][1,3]tiazepin-7-carboxamido útiles en la terapia para el vih y para el tratamiento del cáncer
WO2021092500A1 (en) * 2019-11-08 2021-05-14 Sanford Burnham Prebys Medical Discovery Institute Inhibitor of apoptosis (iap) protein antagonists
US20230295181A1 (en) * 2020-04-30 2023-09-21 Sanford Burnham Prebys Medical Discovery Institute Inhibitor of apoptosis (iap) protein antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20141253T1 (en) 2006-05-05 2015-03-13 The Regents Of The Universitiy Of Michigan Intermediates for the preparation of bivalent smac mimetics
US8202902B2 (en) * 2006-05-05 2012-06-19 The Regents Of The University Of Michigan Bivalent SMAC mimetics and the uses thereof
US20100317593A1 (en) 2009-06-12 2010-12-16 Astrazeneca Ab 2,3-dihydro-1h-indene compounds
CA2789879A1 (en) 2009-10-28 2011-05-19 Joyant Pharmaceuticals, Inc. Dimeric smac mimetics
CA2896577C (en) 2012-11-30 2024-01-23 Sanford-Burnham Medical Research Institute Inhibitor of apoptosis protein (iap) antagonists
EP3151920B1 (en) 2014-06-04 2025-08-06 Sanford-Burnham Medical Research Institute Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy
MX2018009913A (es) * 2016-02-16 2018-11-29 Massachusetts Inst Technology Aglutinantes max como moduladores myc y sus usos.
US10870663B2 (en) * 2018-11-30 2020-12-22 Glaxosmithkline Intellectual Property Development Limited Compounds useful in HIV therapy
AR117206A1 (es) 2018-11-30 2021-07-21 Glaxosmithkline Ip Dev Ltd Derivados de octahidropirrolo[2,1-b][1,3]tiazepin-7-carboxamido útiles en la terapia para el vih y para el tratamiento del cáncer
WO2021092500A1 (en) * 2019-11-08 2021-05-14 Sanford Burnham Prebys Medical Discovery Institute Inhibitor of apoptosis (iap) protein antagonists

Similar Documents

Publication Publication Date Title
RU2495044C2 (ru) Ингибиторы активности протеинтирозинкиназы
EA201070871A1 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
ATE421322T1 (de) Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
EA202090553A1 (ru) Производные 3-(1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и варианты их применения
RU2488582C2 (ru) Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение
JP2020534361A5 (enExample)
JP2014500870A5 (enExample)
JP2010530372A5 (enExample)
CY1117576T1 (el) Δινουκλεοτιδικα προφαρμακα
RU2013152132A (ru) Борсодержащие малые молекулы в качестве противовоспалительных средств
JP2015143283A5 (enExample)
JP2010504346A5 (enExample)
RU2010140627A (ru) Производные пирролидина
DE602007008616D1 (de) Verfahren zur herstellung von 4'-azidocytidinderivaten
ATE547417T1 (de) Dihydropyrimidinverbindungen und ihre verwendungen bei der herstellung von medikamenten zur behandlung und prävention antiviraler krankheiten
FI3546462T3 (fi) Uusi oksoisokinoliinijohdannainen
CY1114865T1 (el) Νεοι αναστολεις seh και η χρηση toyς
JP2013533253A5 (enExample)
JP2016531126A5 (enExample)
RU2012155118A (ru) Способы лечения биполярного расстройства
EA202193007A1 (ru) Соединения пирролидина
RU2006130000A (ru) Органические соединения
JP2020531526A5 (enExample)
JP2018529690A5 (enExample)
JP2018529648A5 (enExample)